ConductScience.org, home

Paper8345587

Hereditary prostate cancer: epidemiologic and clinical features.

Carter BS and 6 others. J Urol, 1993. Cited by 425 papers, by iCite.

Cite this record

ConductScience Library. Hereditary prostate cancer: epidemiologic and clinical features. Papers, record 8345587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8345587

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hereditary prostate cancer: epidemiologic and clinical features.
PubMed
Journal
J Urol
PubMed
Year
1993
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
425
iCite
Relative citation ratio, by iCite
11.3
iCite
Revised in PubMed
2019-06-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carter BSB S
2Bova GSG S
3Beaty THT H
4Steinberg GDG D
5Childs BB
6Isaacs WBW B
7Walsh PCP C

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Humans
Male
Models, Biological
Pedigree
Risk Factors

Cited by124

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 425 citations.

PMIDTitleJournalYearIn PapersSource
40891997Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer.BJU Int2025https://conductscience.org/library/papers/40891997PubMed
39874495Coding Variants of the Genitourinary Development Gene WNT9B Carry High Risk for Prostate Cancer.JCO Precis Oncol2025https://conductscience.org/library/papers/39874495PubMed
39807695Exploring experimental models of prostate cancer in chemoprevention: Oxidative stress as a key pathway to translational research.Pathol Int2025https://conductscience.org/library/papers/39807695PubMed
38736618Cribiform and intraductal carcinoma in hereditary prostate cancer: clinical and pathological analysis of 20 cases.Am J Clin Exp Urol2024https://conductscience.org/library/papers/38736618PubMed
38534919Review on the Role of BRCA Mutations in Genomic Screening and Risk Stratification of Prostate Cancer.Curr Oncol2024https://conductscience.org/library/papers/38534919PubMed
37528288Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer.World J Urol2023https://conductscience.org/library/papers/37528288PubMed
37046747High-Risk Pedigree Study Identifies LRBA (rs62346982) as a Likely Predisposition Variant for Prostate Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/37046747PubMed
36434163Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine.Prostate Cancer Prostatic Dis2023https://conductscience.org/library/papers/36434163PubMed
36060024Variants in HOXB13, G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men.Cancer Diagn Progn2022https://conductscience.org/library/papers/36060024PubMed
35449224Germline testing and genetic counselling in prostate cancer.Nat Rev Urol2022https://conductscience.org/library/papers/35449224PubMed
35104804Health inequity drives disease biology to create disparities in prostate cancer outcomes.J Clin Invest2022https://conductscience.org/library/papers/35104804PubMed
34211358Innovations in 3-Dimensional Tissue Models of Human Brain Physiology and Diseases.Adv Funct Mater2020https://conductscience.org/library/papers/34211358PubMed
34164591Inherited Mutations in Men Undergoing Multigene Panel Testing for Prostate Cancer: Emerging Implications for Personalized Prostate Cancer Genetic Evaluation.JCO Precis Oncol2017https://conductscience.org/library/papers/34164591PubMed
34118026Recent Insights on Genetic Testing in Primary Prostate Cancer.Mol Diagn Ther2021https://conductscience.org/library/papers/34118026PubMed
34059701Prostate cancer risk variants of the HOXB genetic locus.Sci Rep2021https://conductscience.org/library/papers/34059701PubMed
33973043Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance.World J Urol2021https://conductscience.org/library/papers/33973043PubMed
33780364Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.Cancer Biomark2021https://conductscience.org/library/papers/33780364PubMed
33721089[Familial prostate cancer and genetic predisposition].Urologe A2021https://conductscience.org/library/papers/33721089PubMed
33486571Genetic predisposition to prostate cancer: an update.Fam Cancer2022https://conductscience.org/library/papers/33486571PubMed
33351846Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort.PLoS One2020https://conductscience.org/library/papers/33351846PubMed

See all 124 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8345587

GET https://conductscience.org/api/papers/v1/8345587/cited_by?page=2